Log in to save to my catalogue

Bupropion-Induced Severe Leukocytosis

Bupropion-Induced Severe Leukocytosis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7678766

Bupropion-Induced Severe Leukocytosis

About this item

Full title

Bupropion-Induced Severe Leukocytosis

Publisher

Palo Alto (CA): Cureus

Journal title

Cureus, 2020-10, Vol.12 (10), p.e11083-e11083

Language

English

Formats

Publication information

Publisher

Palo Alto (CA): Cureus

Subjects

More information

Scope and Contents

Contents

Bupropion hydrochloride is a norepinephrine-dopamine reuptake inhibitor approved for the treatment of depression and smoking cessation. Although cardiovascular and hematological side effects are common with bupropion along with weight loss and headache, hematological side effects are rarely reported other than few post marketing studies. Here we pr...

Alternative Titles

Full title

Bupropion-Induced Severe Leukocytosis

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7678766

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7678766

Other Identifiers

ISSN

2168-8184

E-ISSN

2168-8184

DOI

10.7759/cureus.11083

How to access this item